SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-045407
Filing Date
2020-08-05
Accepted
2020-08-05 21:54:50
Documents
1
Period of Report
2020-08-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 1565
  Complete submission text file 0001209191-20-045407.txt   3160
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Issuer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1 WALL STREET BURLINGTON MA 01803
Business Address 1 WALL STREET BURLINGTON MA 01803 781-652-7800
SEKISUI DIAGNOSTICS, LLC (Reporting) CIK: 0001812012 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37428 | Film No.: 201079556